Effect of sample size on reproducibility. by Jan Willem Koten (17743224)

Subjects:

Effect of corrections on connectivity maps. by Jan Willem Koten (17743224)

Subjects:

Impact of corrections on connectivity. by Jan Willem Koten (17743224)

Subjects:

S1 Data - by Jan Willem Koten (17743224)

Subjects:

Connectivity statistics. by Jan Willem Koten (17743224)

Subjects:

Hypothetical versus random connectomes. by Jan Willem Koten (17743224)

Subjects:

Thresholds and group reproducibility. by Jan Willem Koten (17743224)

Subjects:

Reproducibility of response time and brain measures. by Jan Willem Koten (17743224)

Subjects:

Projected global leukemia burden, 1990-2050. by Chengjun Hu (588206)

“…<div><p>Background: Leukemia is a prevalent form of cancer that encompasses four primary subtypes, posing significant health risks. Gaining insights into the global epidemiology of leukemia and its subtypes is crucial for effective resource allocation, clinical guidance, and scientific inquiry. …”

Correlation between HDI and EAPC. by Chengjun Hu (588206)

“…<div><p>Background: Leukemia is a prevalent form of cancer that encompasses four primary subtypes, posing significant health risks. Gaining insights into the global epidemiology of leukemia and its subtypes is crucial for effective resource allocation, clinical guidance, and scientific inquiry. …”

Global leukemia incidence and EAPC, 1990-2021. by Chengjun Hu (588206)

“…<div><p>Background: Leukemia is a prevalent form of cancer that encompasses four primary subtypes, posing significant health risks. Gaining insights into the global epidemiology of leukemia and its subtypes is crucial for effective resource allocation, clinical guidance, and scientific inquiry. …”

Distribution of deaths caused by risk factors for four major female-specific cancers between 2000 and 2021 across 51 U.S. states. by Ze Zhang (47230)

Subjects:

Age-standardized four major female-specific cancers incidence (2017-2021) among non-Hispanic White population across 51 U.S. states. by Ze Zhang (47230)

Subjects:

Joinpoint trends in age-standardized mortality rates for the major female-specific cancers by race and ethnicity in the United States, 2000–2022. by Ze Zhang (47230)

Subjects:

Age-standardized incidence (2017–2021) and death (2018–2022) rate of four major female-related cancer among the non-Hispanic White population by state, United States. by Ze Zhang (47230)

Subjects:

Average annual age-standardized incidence (2017–2021) and death (2018–2022) rates and rate ratios with 95% confidence intervals for major female-specific cancers by race and ethnic... by Ze Zhang (47230)

Subjects:

Trends in annual age-standardized rates for six major female-specific cancers mortality (2000–2022) by race and ethnicity in the USA. by Ze Zhang (47230)

Subjects:

Trends in annual age-standardized rates for six major female-specific cancers incidence (2000-2021) by race and ethnicity in the USA. by Ze Zhang (47230)

Subjects:

Trends in age-standardized death rates attributable to specific risk factors for four major female-specific cancers incidence (2000–2021) in the USA. by Ze Zhang (47230)

Subjects:

Age-standardized four major female-specific cancers mortality (2018-2022) among non-Hispanic White population across 51 U.S. states. by Ze Zhang (47230)

Subjects: